Use of odorants to alter blood flow to the vagina, and article of manufacture thereof
A non-invasive method of altering vaginal blood flow in a female individual to augment or lessen sexual arousal is provided. The method involves administering an individual odorant or odorant mixture for inhalation that is sufficient to alter vaginal blood flow of the female by about −20% to about +30% compared to a baseline vaginal blood flow without inhalation of the odorant. Also provided is a method for screening an odorant for its capacity to increase or decrease vaginal blood flow, and an article of manufacture, or kit, containing an odorant and instructions for its use in altering vaginal blood flow.
1. An article of manufacture, comprising, packaged together:
a liquid odorant composition packaged in a container, the odorant composition comprising a mixture of odorants in a suprathreshold but not irritant concentration, said concentrations of the odorants being greater than an average normal threshold concentration of the odorants, said concentration being about 25–55 decismel units and effective to alter blood flow to the vagina when inhaled by a female individual; wherein the odorant mixture is selected from the group consisting of a mixture of licorice-based and banana nut bread odorants, a mixture of licorice-based and cucumber odorants, and a mixture of baby powder and chocolate odorants; and
instructions for administering the odorant to alter blood flow to the vagina.
2. The article of manufacture of claim 1 , wherein the odorant composition and the unit dosage amount of the odorant composition is effective to increase blood flow to the vagina of the female individual by about 10–30%.
3. The article of manufacture of claim 1 , wherein the odorant composition and the unit dosage amount of the odorant composition is effective to decrease blood flow to the vagina of the female individual by about 10–20%.
4. An article of manufacture, comprising, packaged together:
an odorant composition packaged in a container, the odorant composition comprising a mixture of odorants in a suprathreshold but not irritant concentration, said concentration of the odorants being greater than an average normal threshold concentration of the odorants, said concentration being about 25–55 decismel units and effective to alter blood flow to the vagina when inhaled by a female individual wherein the odorant mixture is selected from the group consisting of a mixture of licorice-based and banana nut bread odorants, a mixture of licorice-based and cucumber odorants, and a mixture of baby powder and chocolate odorants;
instructions for administering the odorant to alter blood flow to the vagina; and at least one of:
(i) a device for measuring blood flow to the vagina of the female individual;
(ii) a device for administering a plurality of odorants for testing olfactory ability of the female individual; and
(iii) a device for administering a series of odorants for testing olfactory threshold of the female individual.
5. The article of manufacture of claim 1 , wherein the odorant composition is packaged within a delivery device selected from the group consisting of a vial, jar, pouch, can, bottle, and a blister pack.
6. The article of manufacture of claim 1 , wherein the odorant composition is contained with a delivery device selected from the group consisting of a scented cloth, an aerosol spray device, a pump-type spray device, a nasal spray device, a vessel having a cap, and a blister pack.
7. The article of manufacture of claim 1 , wherein the odorant composition is contained in a dispenser comprising a capped vessel having a tin impregnated with the odorant composition.
8. An article of manufacture, comprising, packaged together:
an odorant composition contained in a dispenser comprising a capped vessel having a tip impregnated with the odorant composition;
the odorant composition comprising a mixture of odorants in a suprathreshold but not irritant concentration effective to alter blood flow to the vagina when inhaled by a female individual; wherein the odorant mixture is selected from the group consisting of a mixture of licorice-based and banana nut bread odorants, a mixture of licorice-based and cucumber odorants, and a mixture of baby powder and chocolate odorants; and
instructions for administering the odorant to alter blood flow to the vagina.
9. The article of manufacture of claim 8 , wherein the dispenser contains the odorant composition absorbed to a wicking material.
10. An article of manufacture, comprising, packaged together:
a liquid odorant composition packaged in a container, the odorant composition comprising a suprathreshold but not irritant concentration of a mixture of a licorice-based odorant and a cucumber odorant effective to alter blood flow to the vagina when inhaled by a female individual, said concentration of the odorants being greater than an average normal threshold concentration of the odorants at about 25–55 decismel units; and
instructions for administering the odorant to alter blood flow to the vagina.
11. An article of manufacture, comprising, packaged together:
an odorant composition packaged in a container, the odorant composition comprising a mixture of baby powder and chocolate odorants in a suprathreshold but not irritant concentration effective to increase blood flow to the vagina when inhaled by a female individual; and
instructions for administering the odorant composition to increase blood flow to the vagina.
12. The article of manufacture of claim 11 , wherein the odorant composition and the unit dosage amount of the odorant composition is effective to increase blood flow to the vagina of the female individual by about 10–30%.
13. An article of manufacture, comprising, packaged together:
an odorant composition in the form of microcapsules contained in a scratch-and-sniff odor patch, the odorant composition comprising a suprathreshold but not irritant concentration of a mixture of a licorice-based odorant and a cucumber odorant effective to alter blood flow to the vagina when inhaled by a female individual, said concentration of the odorants being greater than an average normal threshold concentration of the odorants at about 25–55 decismel units; and
instructions for administering the odorant to decrease blood flow to the vagina.
14. The article of manufacture of claim 13 , wherein the odorant composition and the unit dosage amount of the odorant composition is effective to decrease blood flow to the vagina of the female individual by about 10–20%.